EMEA-001039-PIP01-10-M02

  • Email
  • Help

Overview

Product details for Xeomin, Bocouture
Invented nameXeomin, Bocouture
Active substance

Clostridium botulinum neurotoxin type A (150 kD), free of complexing proteins

Decision numberP/0157/2016
PIP numberEMEA-001039-PIP01-10-M02
Pharmaceutical form(s)Powder for solution for injection
Condition(s)/indication(s)

Treatment of muscle-induced wrinkles

Treatment of dystonia

Treatment of muscle spasticity

Route(s) of administrationIntramuscular use
PIP applicant

Merz Pharmaceuticals GmbH 
Germany
Tel. +49 6915031 
Fax +49 691503200
E-mail: contact@merz.de

Decision typePM: decision on the application for modification of an agreed PIP
Compliance check procedure numberEMEA-C-001039-PIP01-10-M02
Compliance check opinion date15/12/2017
Compliance check outcomePositive

Decision